Brennan Aoife
SEC insider (Form 3/4/5 filer). CIK 0001714563. Director at Xilio Therapeutics, Inc. (XLO) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in WALTHAM, MA.
Companies Brennan Aoife has filed insider reports for
- Xilio Therapeutics, Inc. (XLO): Director
- Climb Bio, Inc. (CLYM): Director, Officer, President and CEO
Brennan Aoife
CIK: 0001714563
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 11, 2026XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares- - Jan 6, 2026CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
700K shares- - Jun 30, 2025CLYM
Climb Bio, Inc.
SaleDirect20.6K shares at avg. $1.22$25K - Jun 27, 2025CLYM
Climb Bio, Inc.
ExerciseDirect68.8K shares- - Jun 11, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
31K shares- - Jan 13, 2025CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
1.2M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 5,000 | - | - | Direct |
| Jan 6, 2026 |  CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 700,000 | - | - | Direct |
| Jun 30, 2025 | CLYM Climb Bio, Inc. | Sale | 20,618 | $1.22 | $25,154 | Direct |
| Jun 27, 2025 | CLYM Climb Bio, Inc. | Exercise | 68,750 | - | - | Direct |
| Jun 11, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 31,000 | - | - | Direct |
| Jan 13, 2025 | CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 1,150,000 | - | - | Direct |
1-6 of 6 transactions